Public | |
Traded as | : Q Russell 2500 Component |
Industry |
Contract Research Organization Pharmaceutical Service Consulting |
Founded | 1982 |
Headquarters | Durham, North Carolina, USA |
Key people
|
Dennis Gillings, Founder Ari Bousbib, Chairman and CEO Tom Pike, Vice-Chairman |
Products | Support services for pharmaceutical, biotech and medical companies and individuals |
Revenue | US$ Approximately $4.2 billion in Service Revenue (2014) |
Number of employees
|
~ 35,000 (2015) |
Website | http://www.quintilesims.com/ |
Quintiles IMS Holdings, Inc., branded as QuintilesIMS is an American multinational company serving the combined industries of health information technologies and clinical research. It is a Fortune 500 company and the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 50,000 employees conducting business in approximately 100 countries.
QuintilesIMS is the world’s largest contract research organization as ranked by reported service revenues, and is focused primarily on Phase II-IV clinical trials and associated laboratory and analytical services.